Lipid-based drug-delivery nanoparticles, including non-lamellar-type, mesophasic
nanostructured materials of lyotropic liquid crystals (LLCs), have been a topic of interest for …

Despite the increasing global incidence of brain disorders, achieving sufficient delivery
towards the central nervous system (CNS) remains a formidable challenge in terms of …

Alzheimer's disease (AD) is an illness that affects people aged 65 or older and affects
around 6.5 million in the United States. Resveratrol is a chemical obtained from natural …

Multiple sclerosis (MS), an autoimmune disease, has been considered an inflammatory
disorder of the central nervous system (CNS) with demyelination and axonal damage …

Since the late 20th century, we have witnessed a growing and substantial advance in
nanomedicine, in part due to the development of multifunctional and multimodal …

Glioblastoma is the most common and aggressive primary brain tumor, whose malignancy is
closely correlated with elevated proto-oncogene c-myc. Intranasal administration emerges …

In recent years, liquid crystals dosage forms has gained immense potential as
pharmaceutical drug delivery system. Liquid crystals (LCs) are also known as mesophase …

The present study aimed to develop polyethylene glycol–liquid crystals (PEG-LC) ointment
formulations, assess their formulation characteristics, and establish their biocompatibility …

Interest in lipid-based lyotropic liquid crystalline nanoparticles (LCNPs) as drug delivery
vehicles continues to grow, owing to their unique structural features. The structure of these …

In the development of nasal‐to‐brain (N2B) drug delivery systems, the key challenge lies in
penetrating the mucus, crossing the nasal epithelial barrier, and achieving broad distribution …